Eledon Pharmaceuticals Inc (ELDN) returns
Eledon Pharmaceuticals returns over 10 years
$1,000 invested in Eledon Pharmaceuticals ten years ago was worth $15.40 at the close on October 30, 2026, with dividends reinvested: an average return of -34.1% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +9.5% | — | $1,095 | -0.9% |
| 3 months | -18.8% | — | $812.32 | +2.1% |
| Year to date | +83.4% | — | $1,834 | +11.7% |
| 1 year | -36.3% | — | $636.78 | +12.4% |
| 3 years | +75.3% | +20.6% | $1,753 | +88.5% |
| 5 years | -44.6% | -11.1% | $554.00 | +76.0% |
| 10 years | -98.5% | -34.1% | $15.40 | +316.6% |
Eledon Pharmaceuticals return by calendar year
| Year | ELDN | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +83.4% | +11.7% | +71.8% |
| 2025 | -63.3% | +17.7% | -81.1% |
| 2024 | +128.9% | +24.9% | +104.0% |
| 2023 | -21.1% | +26.2% | -47.2% |
| 2022 | -48.3% | -18.2% | -30.1% |
| 2021 | -71.4% | +28.7% | -100.1% |
| 2020 | +47.5% | +18.4% | +29.1% |
| 2019 | -63.7% | +31.2% | -95.0% |
| 2018 | -60.6% | -4.6% | -56.0% |
| 2017 | -53.9% | +21.7% | -75.6% |
| 2016 | -88.8% | +12.0% | -100.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Eledon Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.